Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: A comparative analysis

Journal of Nuclear Medicine

Volumn 46, Issue 12, 2005, Pages 1959-1972

  Lopresti, Brian J ^a,b   Klunk, William E ^a   Mathis, Chester A ^a   Hoge, Jessica A ^a   Ziolko, Scott K ^a   Lu, Xueling ^a   Meltzer, Carolyn C ^a   Schimmel, Kurt ^a   Tsopelas, Nicholas D ^a   DeKosky, Steven T ^a   Price, Julie C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PET Facility   (United States)

Author keywords

Alzheimer's disease; Amyloid; PET; Pittsburgh Compound B

Indexed keywords

AMYLOID; CARBON 11; N METHYL 2 (4' METHYLAMINOPHENYL) 6 HYDROXYBENZOTHIAZOLE C 11; PITTSBURGH COMPOUND B; UNCLASSIFIED DRUG; 2 (4' (METHYLAMINO)PHENYL) 6 HYDROXYBENZOTHIAZOLE; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; ANILINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; THIAZOLE DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BRAIN; CAROTID ARTERY; CHEMISTRY; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; IMAGE PROCESSING; KINETICS; METHODOLOGY; PATHOLOGY; SCINTISCANNING; TIME;

ALZHEIMER DISEASE; AMYLOID; ANILINE COMPOUNDS; BRAIN; CAROTID ARTERIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; KINETICS; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; THIAZOLES; TIME FACTORS;

EID: 33644876596     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Agdeppa ED, Kepe V, Liu J, et al. 2-Dialkylamino-6-acylmalononitrile substituted naphthalenes (DDNP analogs): novel diagnostic and therapeutic tools in Alzheimer's disease. Mol Imaging Biol. 2003;5:404-417.
2. Klunk WE, Wang Y, Huang GF, et al. The binding of 2-(4′- methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci. 2003;23:2086-2092.
3. Kung MP, Zhuang ZP, Hou C, Kung HF. Development and evaluation of iodinated tracers targeting amyloid plaques for SPECT imaging. J Mol Neurosci. 2004;24:49-53.
4. 11C-Labeled stilbene derivatives as Aβ-aggregate-specific PET imaging agents for Alzheimer's disease. Nucl Med Biol. 2003;3:565-571.
5. 11C-labeled 6-substituted 2-aryl benzothiazoles as amyloid imaging agents. J Med Chem. 2003;46:2740-2754.
6. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol. 2004;55:306-319.
7. Shoghi-Jadid K, Small GW, Agdeppa ED, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry. 2002;10:24-35.
8. 11C]SB-13 PET. Am J Geriatr Psychiatry. 2004;12:584-595.
9. Price JC, Klunk WE, Lopresti BJ, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B. J Cereb Blood Flow Metab. 2005;25:1528-1547.
10. Wilson AA, Garcia A, Chestakova A, Kung HF, Houle S. A rapid one-step radiosynthesis of the beta-amyloid imaging radiotracer N-methyl-[C-11]2- (4′-methylaminophenyl)-6-hydroxybenzothiazole ([C-11]-6-OH-BTA-1). J Labelled Compds Radiopharm. 2004;47:679-682.
11. Watson CC. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl Sci. 2000;47:1587-1594.
12. Meltzer CC, Kinahan PE, Greer PJ, et al. Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med. 1999;40:2053-2065.
13. Meltzer CC, Zubieta JK, Links JM, Brakeman P, Stumpf MJ, Frost JJ. MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution. J Cereb Blood Flow Metab. 1996;16:650-658.
14. Minoshima S, Koeppe RA, Mintun MA, et al. Automated detection of the intercommissural line for stereotactic localization of functional brain images. J Nucl Med. 1993;34:322-329.
15. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr. 1993;17:536-546.
16. 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse. 2002;46:170-188.
17. 11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740-747.
18. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol. 1989;135:309-319.
19. Mintun MA, Raichle ME, Kilbourn MR, Woolen GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984;15:217-227.
20. Thie JA. Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med. 2004;45:1431-1434.
21. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834-840.
22. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4(3 part 1):153-158.
23. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279-287.
24. Hollander M, Wolfe D. Nonparametric Statistical Methods. New York, NY: John Wiley and Sons; 1973.
25. Storey JD. A direct approach to false discovery rates. J Royal Stat Soc B. 2002;64:479-498.
26. Cohen J. Statistical Power for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
27. Hedges LV, Olkin I. Statistical Methods for Meta-Analysis. Orlando, FL: Academic Press; 1985.
28. 18F]altanserin in the human brain. Synapse. 1998;30:380-392.
29. Volkow ND, Fowler JS, Wang GJ, et al. Reproducibility of repeated measures of carbon-11 raclopride binding in the human brain. J Nucl Med. 1991;34:609-613.
30. 18F-fluoro-2-deoxyglucose, the Patlak method, and an image-derived input function. J Cereb Blood Flow Metab. 1998;18:716-723.
31. 11C]flumazenil kinetic analysis in human brain. Mol Imaging Biol. 2003;5:72-78.
32. 18F] cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab. 1993;13:24-42.
33. 18F-FDG PET of breast cancer: characterization and method to adjust for time differences. J Nucl Med. 2003;44:1044-1050.